Targeting Beta-Amyloid Pathogenesis Through Acetylcholinesterase Inhibitors

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4377-4387

Bentham Science Publishers

Access to resources Recommend Favorite

Dangerous Liaisons between Beta-Amyloid and Cholinergic Neurotransmission

By  

Current Pharmaceutical Design, Vol. 20, Iss. 15, 2014-05 ,pp. : 2525-2538

Bentham Science Publishers

Access to resources Recommend Favorite

Brain Clearance of Alzheimer's Amyloid-β40 in the Squirrel Monkey: A SPECT Study in a Primate Model of Cerebral Amyloid Angiopathy

By Bading James R.   Yamada Shinya   Mackic Jasmina B.   Kirkman Linda   Miller Carol   Calero Miguel   Ghiso Jorge   Frangione Blas   Zlokovic Berislav V.  

Journal of Drug Targeting, Vol. 10, Iss. 4, 2002-01 ,pp. : 359-368

Informa Healthcare

Access to resources Recommend Favorite

beta-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer Disease Dream or Reality?

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-07 ,pp. : 175-186

Bentham Science Publishers

Access to resources Recommend Favorite

Clearance of Amyloid-#946; Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 1, 2009-03 ,pp. : 16-30

Bentham Science Publishers

Access to resources Recommend Favorite